Sera PrognosticsMay 20, 2022Sera Prognostics Presents Data Demonstrating the Health & Economic Benefit of PRETRM® Testing at Ispor Annual Meeting
Sera PrognosticsMay 5, 2022Sera Prognostics and Newborn Foundation Partner to Reduce Risks Associated with Preterm Birth and Improve Health Equity Through the “Every Mother, Every Baby” Project
Sera PrognosticsMarch 18, 2022Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting
AviveMarch 16, 2022Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest
EpitelFebruary 16, 2022Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
AtaCor MedicalDecember 20, 2021AtaCor Medical Completes Enrollment in its Initial Acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study
Sera PrognosticsNovember 4, 2021Sera Prognostics Announces Collaboration to Help Underserved Communities Make Informed Decision about Prenatal Health
PanTher TherapeuticsOctober 15, 2021PanTher Therapeutics Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer
Sera PrognosticsSeptember 15, 2021Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
